美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

美国 · SEC FORM 4

Zentalis Pharmaceuticals, Inc.

ZNTL · Nasdaq · CIK 0001725160 · Healthcare · Biotechnology

内部人信号

57.8 / 100

1 位买方 · 1 条买入交易行 · $15.2M 买入总额

为什么有这个信号？

买方广度较低

买入规模较强

角色中等

近期性较低

确信度较强

评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35

买入规模+23.4 / 25

角色+14.0 / 20

近期性+3.4 / 10

确信度+10.0 / 10

哪些因素限制了当前分数？

⚠ Cluster breadth is moderate · 1 insider(s), not 4+
⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct

Walker Luke NathanielDirector

○

Skvarka JanDirector

○

Myers Scott DunsethDirector

○

Kariuki EnochDirector

○

Johnson David MichaelDirector

○

Campbell ShannonDirector

○

● 买入▼ 卖出○ 其他

Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方1

买入集中度100%最大买方： WALTERS GROUP; WALTERS SUSAN BERKLEY; WALTERS WILLIAM THURMAN · $15.2M

聚集买入 · 15天1 insider峰值活动： 2026-08-14–2026-08-14

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

57.8 / 100

近期 Form 4 活动

2买入

10卖出

7其他 Form 4 交易行

14SEC 申报 · 365天

买入1 qualifying P line(s) · 180 days

卖出0 sale line(s) · 仅供背景

其他7 exercise / withholding / award / gift / other lines

10b5-1／计划交易Not detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M: -26.5%
3M: -42.9%
6M: -60.1%
12M: +61.0%

波动率与流动性

波动率: 112.1%
Beta: —
平均每日成交额: USD 3.2M

估值

市值: USD 189.2M
P/E: —

基本面

利润率: —
ROE: -63.4%
细分行业: Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-03 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数: 5,957,612
上期报告: 4,786,334
日均成交量: 1,441,036
回补天数: 4.1

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction date	Reporting owner	类型	证券	股数	平均价格	估算金额	来源
2026-08-14	WALTERS GROUP; WALTERS SUSAN BERKLEY; WALTERS WILLIAM THURMAN	买入 (P)	Common Stock	4,335,000	USD 3.50	USD 15,172,500	SEC 申报 ↗
2025-12-31	WALTERS GROUP; WALTERS SUSAN BERKLEY; WALTERS WILLIAM THURMAN	买入 (P)	Common Stock	6,459,973	USD 1.20	USD 7,751,968	SEC 申报 ↗
2025-04-30	Myers Scott Dunseth	买入 (P)	Common Stock	21,000	USD 1.40	USD 29,400	SEC 申报 ↗
2025-02-06	Bruns Ingmar	买入 (P)	Common Stock	20,000	USD 2.28	USD 45,600	SEC 申报 ↗
2025-01-31	Walker Luke Nathaniel	买入 (P)	Common Stock	14,200	USD 1.76	USD 24,992	SEC 申报 ↗
2025-01-31	Skvarka Jan	买入 (P)	Common Stock	60,000	USD 1.72	USD 103,200	SEC 申报 ↗
2025-01-31	EASTLAND JULIA MARIE	买入 (P)	Common Stock	28,500	USD 1.73	USD 49,305	SEC 申报 ↗
2023-11-13	Blackwell Kimberly	买入 (P)	Common Stock	5,000	USD 10.29	USD 51,450	SEC 申报 ↗
2023-11-10	Johnson David Michael	买入 (P)	Common Stock	17,000	USD 9.88	USD 167,960	SEC 申报 ↗
2023-06-20	GOEL DAVID E.; Matrix Capital Management Company, LP	买入 (P)	Common Stock, par value $0.001 per share	4,760,000	USD 22.66	USD 107,861,600	SEC 申报 ↗
2021-08-19	Epperly Melissa B,	买入 (P)	Common Stock	8,285	USD 52.00	USD 430,820	SEC 申报 ↗
2021-08-18	Epperly Melissa B,	买入 (P)	Common Stock	1,326	USD 52.00	USD 68,952	SEC 申报 ↗
2020-04-07	Johnson David Michael	买入 (P)	Common Stock	4,000	USD 18.00	USD 72,000	SEC 申报 ↗
2020-04-07	SUN ANTHONY Y	买入 (P)	Common Stock	888	USD 18.00	USD 15,984	SEC 申报 ↗
2020-04-07	Epperly Melissa B,	买入 (P)	Common Stock	20,000	USD 18.00	USD 360,000	SEC 申报 ↗

Form 4 申报证据

19 transaction lines in the latest 365-day window; 560 in local history.

日期	申报人	类型	证券	股数	平均价格	估算金额	来源
2026-09-30	Bruns Ingmar	奖励／授予 (A)	Common Stock	9,727	USD 2.18	USD 21,205	SEC 申报 ↗
2026-08-14	WALTERS GROUP; WALTERS SUSAN BERKLEY; WALTERS WILLIAM THURMAN	买入 (P)	Common Stock	4,335,000	USD 3.50	USD 15,172,500	SEC 申报 ↗
2026-06-16	Walker Luke Nathaniel	奖励／授予 (A)	Common Stock	57,100	USD 0.00	USD 0	SEC 申报 ↗

展开近期 Form 4 证据 (19 grouped rows)

日期	申报人	类型	证券	股数	平均价格	估算金额	来源
2026-09-30	Bruns Ingmar	奖励／授予 (A)	Common Stock	9,727	USD 2.18	USD 21,205	SEC 申报 ↗
2026-08-14	WALTERS GROUP; WALTERS SUSAN BERKLEY; WALTERS WILLIAM THURMAN	买入 (P)	Common Stock	4,335,000	USD 3.50	USD 15,172,500	SEC 申报 ↗
2026-06-16	Walker Luke Nathaniel	奖励／授予 (A)	Common Stock	57,100	USD 0.00	USD 0	SEC 申报 ↗
2026-06-16	Skvarka Jan	奖励／授予 (A)	Common Stock	57,100	USD 0.00	USD 0	SEC 申报 ↗
2026-06-16	Myers Scott Dunseth	奖励／授予 (A)	Common Stock	57,100	USD 0.00	USD 0	SEC 申报 ↗
2026-06-16	Kariuki Enoch	奖励／授予 (A)	Common Stock	57,100	USD 0.00	USD 0	SEC 申报 ↗
2026-06-16	Johnson David Michael	奖励／授予 (A)	Common Stock	57,100	USD 0.00	USD 0	SEC 申报 ↗
2026-05-26	Campbell Shannon	奖励／授予 (A)	Common Stock	114,200	USD 0.00	USD 0	SEC 申报 ↗
2026-02-10	Vultaggio Vincent	卖出 (S)	Common Stock	6,894	USD 2.42	USD 16,683	SEC 申报 ↗
2026-02-09	Vultaggio Vincent	卖出 (S)	Common Stock	3,379	USD 2.39	USD 8,076	SEC 申报 ↗
2026-02-09	EASTLAND JULIA MARIE	卖出 (S)	Common Stock	889	USD 2.39	USD 2,125	SEC 申报 ↗
2026-02-09	Bruns Ingmar	卖出 (S)	Common Stock	335	USD 2.39	USD 801	SEC 申报 ↗
2026-02-06	Vultaggio Vincent	卖出 (S)	Common Stock	29,951	USD 2.43	USD 72,781	SEC 申报 ↗
2026-02-06	EASTLAND JULIA MARIE	卖出 (S)	Common Stock	7,866	USD 2.43	USD 19,114	SEC 申报 ↗
2026-02-06	Bruns Ingmar	卖出 (S)	Common Stock	2,962	USD 2.43	USD 7,198	SEC 申报 ↗
2026-02-03	Vultaggio Vincent	卖出 (S)	Common Stock	556	USD 2.52	USD 1,401	SEC 申报 ↗
2026-02-02	Vultaggio Vincent	卖出 (S)	Common Stock	2,540	USD 2.55	USD 6,477	SEC 申报 ↗
2025-12-31	WALTERS GROUP; WALTERS SUSAN BERKLEY; WALTERS WILLIAM THURMAN	买入 (P)	Common Stock	6,459,973	USD 1.20	USD 7,751,968	SEC 申报 ↗
2025-12-15	GOEL DAVID E.; Matrix Capital Management Company, LP	卖出 (S)	Common Stock, par value $0.001 per share	7,500,000	USD 1.33	USD 9,975,000	SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期	2026-10-18
排名版本	US-v1.2
数据质量	PASS ELIGIBLE · —
股票代码	ZNTL
CIK	0001725160
行业	Healthcare
细分行业	Biotechnology Yahoo Finance
SEC SIC	2834 Pharmaceutical Preparations
交易所	Nasdaq

数据覆盖

本地 Form 4 历史	560 transaction lines from 2020-04-07 to 2026-09-30 17 P purchase lines · 451 S sale lines · 92 other lines
SEC 公司申报	打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.